AtaiBeckley's BPL-003 has aligned its research with the FDA's feedback and will proceed with a two-study Phase 3 trial. Read ...
Hengrui Pharma, a global pharmaceutical company focused on scientific and technological innovation, and Novaliq GmbH ...
Cabaletta offers a de-risked, breadth-first CAR-T platform for autoimmune diseases, with strong EULAR 2026 data and a ...
The Seahawks will likely be shorthanded again in their secondary when they face the Jaguars on Sunday. Safety Julian Love (hamstring), cornerback Devon Witherspoon (knee) and cornerback Riq Woolen ...
Data demonstrate favorable safety and tolerability profile, robust B-cell depletion, and encouraging platelet responses in heavily pretreated patients with primary immune thrombocytopenia Enrollment ...
Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. I tried the viral 6-6-6 challenge: walking an hour a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results